EP 2010215 A2 20090107 - USES AND COMPOSITIONS FOR TREATMENT OF CROHN'S DISEASE
Title (en)
USES AND COMPOSITIONS FOR TREATMENT OF CROHN'S DISEASE
Title (de)
VERFAHREN UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON MORBUS CROHN
Title (fr)
UTILISATIONS ET COMPOSITIONS POUR LE TRAITEMENT DE LA MALADIE DE CROHN
Publication
Application
Priority
- US 2007008962 W 20070410
- US 79090906 P 20060410
- US 80261606 P 20060522
- US 80285806 P 20060522
- US 80977006 P 20060530
- US 81548906 P 20060620
- US 84996706 P 20061006
- US 90462607 P 20070301
- US 90463707 P 20070301
- US 91817407 P 20070314
Abstract (en)
[origin: WO2007120720A2] The invention provides methods, uses and compositions for the treatment of Crohn's disease. The invention describes methods and uses for treating Crohn's disease, wherein a TNFcc inhibitor, such as a human TNF oc antibody, or antigen-binding portion thereof, is used to induce and maintain remission of Crohn's disease in a subject. Also described are methods for determining the efficacy of a TNFa inhibitor for treatment of Crohn's disease in a subject.
IPC 8 full level
A61K 39/395 (2006.01)
CPC (source: EP)
A61P 1/00 (2017.12); A61P 17/06 (2017.12); A61P 29/00 (2017.12); A61P 37/02 (2017.12); C07K 16/241 (2013.01); A61K 2039/505 (2013.01); C07K 2317/21 (2013.01)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK RS
DOCDB simple family (publication)
WO 2007120720 A2 20071025; WO 2007120720 A3 20071221; CA 2564435 A1 20071010; EP 2010215 A2 20090107; EP 2010215 A4 20100616; EP 2666480 A2 20131127; EP 2666480 A3 20140730
DOCDB simple family (application)
US 2007008962 W 20070410; CA 2564435 A 20061030; EP 07755288 A 20070410; EP 13173241 A 20070410